Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.
Girls who are taller and leaner have a higher risk of developing endometriosis later in life, a 66-year follow-up Danish study suggests. Identifying these risk factors during childhood may ... Read more
A collaboration between Evotec and Bayer has led to the advancement of a fourth therapeutic candidate for endometriosis to Phase 1 clinical trials. Evotec and Bayer began their collaboration ... Read more
The glioma-associated oncogene homolog 1 (GLI1) protein may contribute to endometriosis progression by promoting cells’ proliferation and ability to invade other tissues, a study suggests. The findings support GLI1 ... Read more
Women with endometriosis have an increased burden of mutations in four genes, called ZNF586, LUZP4, POP4 and UNC5CL, new data from Predictive Laboratories show. This is the first time these ... Read more
Endometriosis patients with thyroid dysfunction may have increased risk of more intense chronic pain and increased disease severity, a study suggests. The study, “Role of thyroid dysimmunity and thyroid ... Read more
Patients with severe endometriosis and pelvic pain show the most pronounced improvements in quality of life within one year after undergoing laparoscopic surgery, a study reports. The study, “Identification ... Read more
AbbVie’s oral medication Orilissa (elagolix) is now available in Canada as a 200-milligram twice-daily dose to treat moderate to severe pain caused by endometriosis. The therapy, developed by AbbVie in collaboration with Neurocrine ... Read more